ZMUni Compliance Centre

From January 24 to February 6, 2026, 12 new cosmetic ingredients (NCIs) have completed notifications with China's National Medical Products Administration (NMPA).     The technical requirements for the 12 NCIs mentioned above have not been disclosed, and they have not yet entered the safety monitoring period. Among them, biotech-based ingredients represent the largest share and have emerged as a key focus in China's NCI notification landscape in recent years.     Chemical Ingredients   Chemical ingredients are characterized by well-defined molecular structures and relatively mature manufacturing processes. Among all NCIs notified to date, chemical ingredients still represent the largest category.   Notification 20260017 by Botanee Group This ingredient marks

    On February 5, 2026, China's National Health Commission (NHC) officially approved 22 substances as "Three-New Food", including 5 new food ingredients, 11 new food additive varieties, and 6new food-related products.   The details of the new food ingredients and additive varieties are as follows:   New food ingredients:   No. Name in CN Name in EN 1 栀子油 Gardenia oil 2 香玉牡丹花 XiangYu peony flower 3 褐藻寡糖 Alginate oligosaccharide 4 长双歧杆菌婴儿亚种 YLGB-1496 Bifidobacterium longum subsp. infantis YLGB-1496 5 亚麻荠籽油 Camelina seed oil   New varieties of food additives   No. Name in EN Remark 1 D-psicose3-epimerase New varieties of enzyme preparation 2 Glucoseisomerase (xyloseisomerase) 3 Deaminase 4 Sucrose

The global cosmetics regulatory environment continues to evolve. To help businesses stay updated with regulatory changes, ZMUni Compliance Center regularly releases a monthly recap of global cosmetics regulations. This article covers the regulatory developments related to cosmetics in China and globally in January 2026, with an emphasis on updates in cosmetic ingredients and cosmetic management, among other areas.     China Cosmetic Regulatory Updates New Cosmetics Ingredients (NCI) In January 2026, 19 new cosmetic ingredients were notified with the China National Medical Products Administration (NMPA). They include:   The technical requirements for the 19 NCIs mentioned above have not been disclosed, and they have not

On February 2, 2026, China's General Administration of Customs (GACC) released its list of non-compliant imported food products for December 2025. A total of 406 batches from 40 countries and regions were denied entry, representing  a month-on-month decrease of approximately 9% (down 38 batches from 444 in November) and a year-on-year decline of about 12% (down 54 batches from 460 in the same period last year).   The rejected shipments covered a wide range of categories, including frozen meat and poultry products, edible oils, beverages, confectionery, aquatic products, preserved fruits, complementary foods for infants and young children, and seasonings. By country of origin, the United

ZMUni Compliance Centre recently supported Shenzhen CynbioX Biotech in completing the Self-GRAS scientific safety evaluation for its AKG and Ca-AKG products under U.S. FDA GRAS guidelines, culminating in expert consensus. As one of the first domestically fermented AKG products to achieve GRAS compliance, this milestone establishes a strong regulatory foundation for entering the U.S. food market and sets a benchmark for process compliance evaluation in China, reinforcing pathways for international expansion in the nutrition and wellness sector.       Core Breakthrough: First Fermentation-Based Certification in China Alpha-Ketoglutaric Acid (AKG) and its calcium salt form (Ca-AKG) are essential components of

China's cosmetic electronic label (e-label) pilot program continues to expand at the provincial level, with both Shanghai and Zhejiang officially releasing their first batches of pilot companies.   On January 23, 2026, the Shanghai Municipal Medical Products Administration (Shanghai MPA) announced the first batch of 40 pilot companies for the city's cosmetic e-label program. Shanghai Guiyan Technology Co., Ltd., a wholly owned subsidiary of ZMUni Compliance Centre, was selected as a pilot participant, recognizing its compliance expertise and digital service capabilities.   Shortly thereafter, on January 30, 2026, the Zhejiang Provincial Medical Products Administration released its first batch of cosmetic

As global regulatory frameworks for cosmetics and food continue to evolve, companies are facing increasingly detailed requirements around ingredient safety, scientific assessment, and market access. Keeping pace with these changes has become an essential part of everyday regulatory and compliance work.   Throughout 2025, ZMUni Compliance Centre has closely tracked regulatory developments across China and major international markets, while continuing to support clients through practical compliance consulting and project-based regulatory services. Alongside this work, we have also continued to share regulatory updates and practical insights through our website, industry events, and professional communication channels.   Based on this ongoing monitoring and

From January 16 to 23, 2026, 3 new cosmetic ingredients (NCIs) have completed notifications with China's National Medical Products Administration (NMPA).     The technical requirements for the 3 NCIs mentioned above have not been disclosed, and they have not yet entered the safety monitoring period.   Marubi's Fifth NCI Notification Gynura divaricata (L.) DC., a member of the Gynura genus in the Asteraceae family, is recognized in China as a medicinal and edible plant. It contains a range of bioactive constituents, including polysaccharides, flavonoids, alkaloids, and anthraquinones, and is associated with anti-inflammatory, hepatoprotective, and lipid-lowering activities.   In 2010, China's former Ministry of Health (now the National Health